| For: | Kamada Y, Sumida Y, Takahashi H, Ishiba H, Kawanaka M, Tada T, Yoneda M, Imajo K, Seko Y, Fujii H, Nakajima A. Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan. World J Gastroenterol 2026; 32(2): 114097 [PMID: 41551835 DOI: 10.3748/wjg.v32.i2.114097] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i2/114097.htm |
| Number | Citing Articles |
| 1 |
Akash Batta, Tanisha Sehgal, Rupak Desai, Juniali Hatwal, Manjeet Kumar Goyal. Do biomarkers matter? Cardiovascular risk stratification in Asian patients with metabolic dysfunction-associated steatotic liver disease in the era of fibrosis-centric assessment. World Journal of Gastroenterology 2026; 32(28): 117181 doi: 10.3748/wjg.117181
|
| 2 |
Mario Romeo, Fiammetta Di Nardo, Claudio Basile, Carmine Napolitano, Paolo Vaia, Luigi Di Puorto, Mattia Indipendente, Alessia De Gregorio, Marcello Dallio, Alessandro Federico. From FIB-4 to the Artificial Intelligence Era: The Evolution of Non-Invasive Tools (NITs) for Tailored Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Livers 2026; 6(4) doi: 10.3390/livers6040071
|